BerGenBio

Be the first to follow this company

www.bergenbio.com/investors

Login in to make your own estimates and see other investors estimates.

ShowingAll content types

Regulatory press release11/6/2024, 6:00 AM

BerGenBio ASA: Invitation to third quarter 2024 results webcast

Regulatory press release11/6/2024, 6:00 AM

BerGenBio ASA: Invitation to third quarter 2024 results webcast

Regulatory press release10/10/2024, 7:31 PM

BGBIO: CEO Martin Olin steps down

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Regulatory press release10/10/2024, 7:31 PM

BerGenBio ASA: CEO Martin Olin steps down

Regulatory press release10/10/2024, 9:07 AM

BerGenBio ASA: Minutes from Extraordinary General Meeting

Regulatory press release10/10/2024, 9:07 AM

BerGenBio ASA: Minutes from Extraordinary General Meeting

Regulatory press release10/7/2024, 5:00 AM

BGBIO: BerGenBio Announces Safety Data from Dose Escalation Phase 1b in First Line NSCLC Patients

Regulatory press release10/7/2024, 5:00 AM

BerGenBio ASA: BerGenBio Announces Safety Data from Dose Escalation Phase 1b in First Line NSCLC Patients

Regulatory press release9/19/2024, 1:00 PM

BERGENBIO ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING

Regulatory press release9/19/2024, 1:00 PM

BerGenBio ASA: BERGENBIO ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING

Regulatory press release9/9/2024, 1:24 PM

BGBIO: BerGenBio to Present Company Update at H.C. Wainright Annual Global Investment Conference

Regulatory press release9/9/2024, 1:24 PM

BerGenBio ASA: BerGenBio to Present Company Update at H.C. Wainright Annual Global Investment Conference

Regulatory press release8/21/2024, 5:00 AM

BerGenBio Second Quarter Results 2024: Solid clinical and financial progress

Regulatory press release8/21/2024, 5:00 AM

BerGenBio ASA: BerGenBio Second Quarter Results 2024: Solid clinical and financial progress

Regulatory press release8/20/2024, 5:00 AM

BGBIO: BerGenBio Collaborates with Tempus to Potentially Accelerate Development in STK11m Non-Small Cell Lung Cancer

Regulatory press release8/20/2024, 5:00 AM

BerGenBio ASA: BerGenBio Collaborates with Tempus to Potentially Accelerate Development in STK11m Non-Small Cell Lung Cancer

Regulatory press release8/15/2024, 7:57 AM

BerGenBio ASA: Registration of share capital reduction

Regulatory press release8/15/2024, 7:57 AM

BerGenBio ASA: Registration of share capital reduction

Regulatory press release8/13/2024, 5:00 AM

BerGenBio ASA: Invitation to second quarter and half year 2024 results webcast

Regulatory press release8/13/2024, 5:00 AM

BerGenBio ASA: Invitation to second quarter and half year 2024 results webcast